Compass Therapeutics, Inc. CMPX
0.69 USD +0.01 (+1.43%)
Regular-session close
0.67 -0.02 -2.27%
After hours · Nov 20, 5:53 PM ET
0.6405 Day range 0.7297
0.6067 52-week range 6.69
- YTD
- -87.18%
- 1 year
- -85.81%
News
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock increased by 16.4% to $3.82 during Friday's after-market session. The market value of their outstanding shares is at $16.1 million. Spectral AI…benzinga.com Wedbush Maintains Neutral on Compass Therapeutics, Lowers Price Target to $0.9 Wedbush analyst Robert Driscoll maintains Compass Therapeutics (NASDAQ:CMPX) with a Neutral and lowers the price target from $1 to $0.9.
benzinga.com Compass Therapeutics Q3 EPS $(0.15) Misses $(0.13) Estimate Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 87.5 percent decrease over losses…
benzinga.com Compass Therapeutics To Present Data On Novel Mechanism Of Action For CTX-10726 At 41st Society For Immunotherapy Of Cancer Annual Meeting CTX-10726, a PD-1 x VEGF-A bispecific antibody discovered and engineered at Compass, exhibits a unique mechanism of action that has not been previously reported in this class of drugs, characterized…
